Insilico Medicine — AI-Powered Drug Discovery Platform
Insilico Medicine uses generative AI and deep learning to discover new drug candidates in months instead of years. Their Pharma.AI platform generates novel molecular structures, predicts clinical trial outcomes, and identifies new disease targets. In 2023, Insilico advanced the first fully AI-discovered drug (for idiopathic pulmonary fibrosis) to Phase II clinical trials — a milestone that previously took the industry 4-5 years and $400M.
Features
✦Generative AI designs novel drug molecules from scratch in 30 days
Let's discuss how Insilico Medicine — AI-Powered Drug Discovery Platform can transform your business. 364 E Main St STE 1008, Middletown, DE 19709 · +1 302 464 0950